University of Alabama at Birmingham — Huntsville, Alabama

Public research footprint of University of Alabama at Birmingham, compiled from the ClinicalTrials.gov public registry.

108

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Major Depressive Disorder · Depressive Episodes, Bipolar I Depression · Autosomal Dominant Polycystic Kidney · Internal Carotid Artery Stenosis

Recently updated registry entries

NCT06547489 — Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder (Recruiting)
NCT07076407 — A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) (Recruiting)
NCT05850689 — Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Alabama at Birmingham?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.